G-Hes supplementation substantially suppressed the increase in kidney weight during DN development (Figure 1C,D), suggesting the preventive effect of G-Hes but not through a mechanism of blood glucose control. This evidence concerns the gene RRBP1 and liver dysplastic nodule.